Operating Expenses - Accelerate Diagnostics Inc (NASDAQ:AXDX) - Alpha Spread

Accelerate Diagnostics Inc
NASDAQ:AXDX

Watchlist Manager
Accelerate Diagnostics Inc Logo
Accelerate Diagnostics Inc
NASDAQ:AXDX
Watchlist
Price: 1.476 USD 0.41%
Market Cap: 34.9m USD
Have any thoughts about
Accelerate Diagnostics Inc?
Write Note

Accelerate Diagnostics Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Accelerate Diagnostics Inc
Operating Expenses Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Accelerate Diagnostics Inc
NASDAQ:AXDX
Operating Expenses
-$46.3m
CAGR 3-Years
14%
CAGR 5-Years
10%
CAGR 10-Years
-7%
Becton Dickinson and Co
NYSE:BDX
Operating Expenses
-$6B
CAGR 3-Years
1%
CAGR 5-Years
-2%
CAGR 10-Years
-7%
Boston Scientific Corp
NYSE:BSX
Operating Expenses
-$7.8B
CAGR 3-Years
-9%
CAGR 5-Years
-8%
CAGR 10-Years
-7%
Stryker Corp
NYSE:SYK
Operating Expenses
-$9.1B
CAGR 3-Years
-9%
CAGR 5-Years
-8%
CAGR 10-Years
-9%
Abbott Laboratories
NYSE:ABT
Operating Expenses
-$15.8B
CAGR 3-Years
-2%
CAGR 5-Years
-3%
CAGR 10-Years
-7%
Intuitive Surgical Inc
NASDAQ:ISRG
Operating Expenses
-$3.1B
CAGR 3-Years
-17%
CAGR 5-Years
-15%
CAGR 10-Years
-14%

See Also

What is Accelerate Diagnostics Inc's Operating Expenses?
Operating Expenses
-46.3m USD

Based on the financial report for Jun 30, 2024, Accelerate Diagnostics Inc's Operating Expenses amounts to -46.3m USD.

What is Accelerate Diagnostics Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-7%

Over the last year, the Operating Expenses growth was 24%. The average annual Operating Expenses growth rates for Accelerate Diagnostics Inc have been 14% over the past three years , 10% over the past five years , and -7% over the past ten years .

Back to Top